News

Drug candidate for severe COVID-19 identified by IMIDomics and VHIR Rheumatology Group selected for NIH clinical trial

IMIDomics funds a study that identifies a new drug candidate to prevent severe COVID-19

IMIDomics funds a study that identifies a new drug candidate to prevent severe COVID-19

Kick-off meeting of the DocTIS project on combinatorial therapies in IMIDs in Barcelona, Spain